| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/12/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 15.7% stake in Orchestra Biomed Holdings, Inc. |
| 04/03/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/24/2023 |
8-K/A
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/13/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.4% stake in Orchestra Biomed Holdings, Inc. |
| 02/14/2023 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 6.1% stake in Orchestra BioMed Holdings Inc |
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/31/2023 |
8-K
| Quarterly results |
| 01/30/2023 |
SC 13D/A
| HSAC 2 Holdings, LLC reports a 16.2% stake in Orchestra Biomed Holdings, Inc. |
| 01/27/2023 |
SC 13D/A
| RTW INVESTMENTS, LP reports a 16.2% stake in Orchestra Biomed Holdings, Inc. |
| 01/25/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 01/25/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/25/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/24/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/10/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/21/2022 |
8-K
| Material Modifications to Rights of Security Holders Interactive Data |
| 12/19/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/16/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 12/12/2022 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 12/01/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/21/2022 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 11/16/2022 |
8-K
| Material Modifications to Rights of Security Holders Interactive Data |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/21/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/21/2022 |
8-K
| Quarterly results |
| 10/12/2022 |
SC 13D
| RTW INVESTMENTS, LP reports a 8.9% stake in Health Sciences Acquisitions Corporation 2 |
| 10/12/2022 |
SC 13D
| HSAC 2 Holdings, LLC reports a 38.9% stake in Health Sciences Acquisitions Corporation 2 |
|